The ADC binds CD30 on target cells and is internalized; the linker is cleaved to release MMAE, which binds β‑tubulin (vinca site) to inhibit microtubule polymerization, causing G2/M arrest and apoptosis. Tubulin itself is not the selective binding target of the drug.